GC
MR

Guggenheim Capital’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Guggenheim Capital’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-28,723
Closed -$778K – 3076
2015
Q4 		$778K Buy
28,723
+16,318
+132% +$420K ﹤0.01% 2222
2015
Q3 		$272K Sell
12,405
-6,141
-33% -$157K ﹤0.01% 2631
2015
Q2 		$528K Sell
18,546
-1,497
-7% -$43.6K ﹤0.01% 2512
2015
Q1 		$548K Sell
20,043
-1,915
-9% -$52.7K ﹤0.01% 2499
2014
Q4 		$580K Sell
21,958
-5,688
-21% -$166K ﹤0.01% 2471
2014
Q3 		$833K Sell
27,646
-474
-2% -$14.7K ﹤0.01% 2331
2014
Q2 		$885K Sell
28,120
-2,638
-9% -$83.7K ﹤0.01% 2337
2014
Q1 		$996K Sell
30,758
-21,568
-41% -$755K ﹤0.01% 2268
2013
Q4 		$1.9M Sell
52,326
-1,440
-3% -$56K 0.01% 1838
2013
Q3 		$2.09M Buy
53,766
+1,850
+4% +$74.5K 0.01% 1591
2013
Q2 		$1.95M Buy
+51,916
New +$2.05M 0.01% 1557

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Guggenheim Capital's MR Position: Q1 2016 in Review

Guggenheim Capital sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 28,723 shares — an estimated $778K sold.

Guggenheim Capital first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $2.09M in Q3 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Guggenheim Capital reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Guggenheim Capital sold 28,723 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $778K.
  • Guggenheim Capital first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Guggenheim Capital's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $2.09M in Q3 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Guggenheim Capital's 13F filing for Q1 2016, filed 16 May 2016.